Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin L Robb

Showing results (251-260 of 358) with videos related to

Pageof 36
Sort By:
Cell Host & Microbe|July 16, 2022
HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotypeShuying S Li, Andrew Hickey, Shida Shangguan, et al.
Open Forum Infectious Diseases|April 30, 2026
A Prospective Incidence Study on Sexually Transmitted Infections and HIV in Men Who Have Sex With Men, With or Without Use of Pre-exposure ProphylaxisKlaus Jansen, Trevor A Crowell, Patrick F Ottensmeyer, et al.
Plos One|September 3, 2015
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized TrialsYunda Huang, Dean Follmann, Martha Nason, et al.
Plos One|April 16, 2015
Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trialPatricia J Munseri, Arne Kroidl, Charlotta Nilsson, et al.
Journal of Virology|May 11, 2018
Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying <i>env</i> from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 TropismHanna B Scinto, Sandeep Gupta, Swati Thorat, et al.
Frontiers in Immunology|January 30, 2023
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinatedJill Maaske, Stephanie Sproule, Ann R Falsey, et al.
The Journal of Clinical Investigation|February 5, 2020
Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruptionJulie L Mitchell, Hiroshi Takata, Roshell Muir, et al.
Lancet (London, England)|December 27, 2014
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trialHannah Kibuuka, Nina M Berkowitz, Monica Millard, et al.
NPJ Vaccines|May 18, 2022
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaquesJohn D Ventura, Joseph P Nkolola, Abishek Chandrashekar, et al.
Plos Computational Biology|February 1, 2021
Factors influencing estimates of HIV-1 infection timing using BEASTBethany Dearlove, Sodsai Tovanabutra, Christopher L Owen, et al.
Pageof 36

Showing results (251-260 of 358) with videos related to

Sort By:
Pageof 36
Cell Host & Microbe|July 16, 2022
HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotypeShuying S Li, Andrew Hickey, Shida Shangguan, et al.
Open Forum Infectious Diseases|April 30, 2026
A Prospective Incidence Study on Sexually Transmitted Infections and HIV in Men Who Have Sex With Men, With or Without Use of Pre-exposure ProphylaxisKlaus Jansen, Trevor A Crowell, Patrick F Ottensmeyer, et al.
Plos One|September 3, 2015
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized TrialsYunda Huang, Dean Follmann, Martha Nason, et al.
Plos One|April 16, 2015
Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trialPatricia J Munseri, Arne Kroidl, Charlotta Nilsson, et al.
Journal of Virology|May 11, 2018
Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying <i>env</i> from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 TropismHanna B Scinto, Sandeep Gupta, Swati Thorat, et al.
Frontiers in Immunology|January 30, 2023
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinatedJill Maaske, Stephanie Sproule, Ann R Falsey, et al.
The Journal of Clinical Investigation|February 5, 2020
Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruptionJulie L Mitchell, Hiroshi Takata, Roshell Muir, et al.
Lancet (London, England)|December 27, 2014
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trialHannah Kibuuka, Nina M Berkowitz, Monica Millard, et al.
NPJ Vaccines|May 18, 2022
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaquesJohn D Ventura, Joseph P Nkolola, Abishek Chandrashekar, et al.
Plos Computational Biology|February 1, 2021
Factors influencing estimates of HIV-1 infection timing using BEASTBethany Dearlove, Sodsai Tovanabutra, Christopher L Owen, et al.
Pageof 36